This Article Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal My Folders Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kivioja, A. Articles by Böhling, T. Search for Related Content PubMed PubMed Citation Articles by Kivioja, A. Articles by Böhling, T.

Chondrosarcoma in a family with multiple hereditary exostoses

Department of Orthopaedics and Traumatology

J. Kinnunen, MD

Department of Radiology

I. Kaitila, MD

Department of Clinical Genetics, Helsinki University Central Hospital, Topeliuksenkatu 5, 00260 Helsinki, Finland.

M. Wolf, MSc

Department of Medical Genetics

T. Böhling, MD

Department of Pathology, University of Helsinki, Haartman Institute, Haartmaninkatu 3, 00290 Helsinki, Finland.

Correspondence should be sent to Dr A. Kivioja.

Multiple hereditary exostoses is an autosomal dominant skeletal disorder in which there are numerous cartilage-capped excrescences in areas of actively growing bone. The condition is genetically heterogeneous, and at least three genes, ext1, ext2 and ext3 are involved. The reported risk for malignant transformation to chondrosarcoma has been from 0.6% to 2.8%. We have reviewed six generations of a family with 114 living adult members, 46 of them with multiple exostoses. Four have had operations for chondrosarcoma, giving the risk for malignant transformation as 8.3% in this family. Clinical and radiological examination revealed two additional patients with a suspicion of malignancy, but in whom the histological findings were benign. Reported elsewhere in detail, genetic linkage analysis mapped the causative gene to chromosome 11 and molecular studies revealed a guanine-to-thymine transversion in the ext2 gene. Patients with multiple hereditary exostoses carry a relatively high risk of malignant transformation. They should be informed of this possibility and regularly reviewed.